Combinations or Single Agents, Crossover or No Crossover: Considering Chemotherapy Strategies in the Multi-Chaptered Story of Metastatic Breast Cancer - a podcast by American Society of Clinical Oncology (ASCO)

This podcast will critically review randomized phase III trial data examining the relative role of taxane
monotherapy versus combination therapy as first-line treatment for HER2-negative metastatic breast
cancer.

Further episodes of Journal of Clinical Oncology (JCO) Podcast

Further podcasts by American Society of Clinical Oncology (ASCO)

Website of American Society of Clinical Oncology (ASCO)